Vaxart, Inc. (VXRT)
NASDAQ: VXRT · Real-Time Price · USD
0.722
+0.001 (0.10%)
Mar 6, 2026, 10:54 AM EST - Market open
Vaxart Employees
Vaxart had 105 employees as of December 31, 2024. The number of employees decreased by 4 or -3.67% compared to the previous year.
Employees
105
Change (1Y)
-4
Growth (1Y)
-3.67%
Revenue / Employee
$1,411,467
Profits / Employee
-$482,886
Market Cap
173.32M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Molecular Partners AG | 153 |
| Nkarta | 105 |
| Tonix Pharmaceuticals Holding | 81 |
| Compugen | 74 |
| SAB Biotherapeutics | 63 |
| Galectin Therapeutics | 15 |
| Sagimet Biosciences | 14 |
| Tiziana Life Sciences | 9 |
VXRT News
- 2 days ago - Vaxart to Host Upcoming Conference Calls - GlobeNewsWire
- 2 months ago - Vaxart to Participate in the Global BioInnovation Forum on January 13, 2026 - GlobeNewsWire
- 3 months ago - Vaxart, Inc. (VXRT) Shareholder/Analyst Call Transcript - Seeking Alpha
- 4 months ago - Vaxart, Inc. (VXRT) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Dynavax Reports Third Quarter 2025 Financial Results and Announces New $100 Million Share Repurchase Program - PRNewsWire
- 4 months ago - Dynavax Enters Exclusive License Agreement for Vaxart's Novel Oral COVID-19 Vaccine Program - PRNewsWire
- 5 months ago - Vaxart to Showcase its Norovirus and COVID-19 Oral Pill Vaccine Candidates at World Vaccine Congress Europe 2025 - GlobeNewsWire
- 6 months ago - Vaxart Appoints W. Mark Watson as Lead Independent Director - GlobeNewsWire